Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Net Margin (2020 - 2025)

RxSight's Net Margin history spans 6 years, with the latest figure at 28.07% for Q4 2025.

  • For Q4 2025, Net Margin fell 8145.0% year-over-year to 28.07%; the TTM value through Dec 2025 reached 28.96%, down 2892.0%, while the annual FY2025 figure was 28.96%, 2892.0% down from the prior year.
  • Net Margin reached 28.07% in Q4 2025 per RXST's latest filing, up from 32.35% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 53.38% in Q4 2024 to a low of 219.03% in Q3 2021.
  • Average Net Margin over 5 years is 76.77%, with a median of 45.48% recorded in 2023.
  • The largest YoY upside for Net Margin was 62745bps in 2021 against a maximum downside of -36052bps in 2021.
  • A 5-year view of Net Margin shows it stood at 186.73% in 2021, then surged by 48bps to 97.03% in 2022, then skyrocketed by 67bps to 32.12% in 2023, then soared by 266bps to 53.38% in 2024, then plummeted by -153bps to 28.07% in 2025.
  • Per Business Quant, the three most recent readings for RXST's Net Margin are 28.07% (Q4 2025), 32.35% (Q3 2025), and 35.04% (Q2 2025).